Schedule 13D ownership disclosure
Timber Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 887080109
Event date: 2021-09-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-114019
- Form type
- SC 13D
- Filer
- TardiMed Sciences LLC
- CIK
- CIK 1800690
- Filed
- Sep 09, 2021
- Reporting period
- Sep 07, 2021
- Description
- Schedule 13D beneficial ownership